Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
BIONOSTRA GROUP Elisabet de los Pinos, PhD Director of Business Development BIO-SCIENCE FORUM New York 8th November 2006 GROUP HISTORY BIONOSTRA GROUP: founded in the year 2000 by: CSIC Scientists Business Executives *CSIC: Consejo Superior de Investigaciones Científicas- The Spanish Highest Council of Scientific Research CORPORATE OVERVIEW BIONOSTRA GROUP Foundation Date: 2000 Nº Employees: 20 Nº Patents: 6 Foundation Date: 2005 Nº Employees: 5 Nº Patents: 3 Foundation Date: 2000 Nº Employees: 25 Product Lines: 2 BIOALMA: STRATEGY VISION: World Leading Bioinformatics company STRATEGY: Combine information technology and biomedical knowledge to provide versatile solutions that meet the specific needs of life science researchers. BIOALMA: PRODUCTS Functional genomics (Microarrays) almaZen System Provides individual researchers and core facilities with a centralized software solution that supports the complete microarray process. Easy-to-use tools help scientists efficiently manage and visualize the large amount of biological samples involved in replicated experiments, and interpret their results. Information extraction: almaKnowledgeServer (AKS) AKS is a biomedical knowledge system that manages information extracted directly from the scientific literature using the most advanced text mining techniques. It provides powerful search and visualization capabilities to navigate the knowledge network and contains functionality to easily identify relevant information. BIOALMA: MARKETING / SALES USA Europe Yashusiro Yogo Chris Wasden Head of Marketing Japan Bilal Yahouie Head of Marketing Head of Marketing Chris Hoover Mr. Tanaka Marketing TimeLogic Representative MICROBIONTA • Early Stage Biotechnology Company • Strategy: Development of New Technologies for Diagnosis and Therapy based on the expression of Recombinant Antibodies in Bacteria • Technology Platforms: - Recombinant Antibody Secretion in Bacteria - Bacterial Display of antibodies MICROBIONTA: TECHNOLOGY Recombinant Ab Ab BACTERIA Single Chain Antibody (scFv) Microbionta owns the Technology which enables the expression of recombinant Ab in Bacteria Camelbody Antibody Secretion INDUSTRIAL APPLICATIONS • Antibody Secretion for the treatment of Intestinal Disorders Bacterial Display • Antibody Selection • Markers for Diagnosis BIONOSTRA: STRATEGY VISION World leader in the development of vaccines based on Virus Like Particles STRATEGY Discovery and Drug Development of new Prophylactic and Therapeutic vaccines based on its BIONIB® VIRUS LIKE PARTICLE TECHNOLOGY PLATFORM BIONIB TECHNOLOGY PLATFORM BIONIB® TECHNOLOGY PLATFORM What are BIONIB® Virus Like Particles? Our technology platform BIONIB® has developed and optimized the large scale production of nanometric particles known as VLPs (virus like particles) structural proteins resembling the live virus particle. What makes this technology valuable? •Biological security (lack of genetic material) •Long term stability •Low cost industrial production in yeast •Multi-epitope expression •Highly immunogenic (no pre-existing antibodies in humans) •Induction of antibodies against disease-related molecules •Activation of cytotoxic T cells •Possibility for nucleic acid encapsidation BIONOSTRA: PIPELINE PRODUCT PIPELINE Human Health Infectious disease Cardiovascular disease Product Indication BIONIB V005 Influenza BIONIB V004 Malaria BIONIB GT001 FH* BIONIB GT002 PAD** Validation Lead optimization Pre-clinical IND Filing Phase I Phase II *FH: Familial Hypercholesterolemia **PAD: Peripheral Arterial Disease Animal Health Infectious disease Product Indication Specie BIONIB Vv001 Gumboro Poultry BIONIB Vv002 Influenza Poultry BIONIB Vv003 FMDV* Swine BIONIB Vv004 Gumboro/Marek Poultry * FMDV: Foot and Mouth Disease Virus Validation Lead optimization Phase I Phase II Phase III BIONOSTRA: Services and Contract Research Biotech Services Food services Animal Facilities Molecular Biology Services • • • • • • • GMO´s detection Race/ Strain / Varieties Identification Species Identification (animal/Vegetables) Winery Industry ( Grape/Yeast Id.) Water (detection of endotoxins) Allergens Detection Hormones/Antibiotics Detection • Health Monitoring • Molecular Markers for Genetic Background • Speed-Congenic • • • • • • Sequencing Cloning Protein Expression Antibody Production Microsatellite Development Quantitative PCR